Technical Analysis for PTCT - PTC Therapeutics, Inc.

Grade Last Price % Change Price Change
C 33.10 -2.75% -0.94
PTCT closed down 2.75 percent on Friday, May 17, 2024, on 76 percent of normal volume.
4 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up

Date Alert Name Type % Chg
Wide Bands Range Expansion 0.00%
Wide Bands Range Expansion -2.75%
180 Bullish Setup Bullish Swing Setup -1.68%
Wide Bands Range Expansion -1.68%
Gapped Up Strength -1.68%
Wide Bands Range Expansion 6.14%
Gapped Up Strength 6.14%
Wide Bands Range Expansion 4.40%
Wide Bands Range Expansion 2.62%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 6.59%

   Recent Intraday Alerts

Alert Time
Down 3% 2 days ago
Fell Below Previous Day's Low 2 days ago
Down 2 % 2 days ago
Down 1% 2 days ago
Up 1% 3 days ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

PTC Therapeutics, Inc. Description

PTC Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of orally administered and proprietary small-molecule drugs for patients living with serious and life-threatening conditions, including genetic and neuromuscular disorders, cancer, and infectious diseases. Its approach includes post-transcriptional control, RNA biology, and gene expression modulation by small-molecules. The company has strategic alliances with AstraZeneca; Celgene Corporation; Cystic Fibrosis Foundation; Genzyme Corporation; Gilead; Muscular Dystrophy Association; Merck & Co., Inc.; Parent Project Muscular Dystrophy; Pfizer Inc.; Roche; Spinal Muscular Atrophy Foundation; and Wellcome Trust. PTC Therapeutics, Inc. was founded in 1998 and is based in South Plainfield, New Jersey.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Biology Infectious Diseases Neurological Disorders Dystrophy Gene Expression Muscular Dystrophy Cystic Fibrosis Neurodegenerative Disorders Transcription Spinal Muscular Atrophy Genzyme Neuromuscular Disorders

Is PTCT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 59.75
52 Week Low 17.53
Average Volume 846,493
200-Day Moving Average 28.16
50-Day Moving Average 29.34
20-Day Moving Average 30.93
10-Day Moving Average 32.29
Average True Range 1.64
RSI (14) 60.47
ADX 30.11
+DI 28.53
-DI 15.83
Chandelier Exit (Long, 3 ATRs) 30.54
Chandelier Exit (Short, 3 ATRs) 28.93
Upper Bollinger Bands 36.88
Lower Bollinger Band 24.98
Percent B (%b) 0.68
BandWidth 38.47
MACD Line 1.34
MACD Signal Line 1.18
MACD Histogram 0.1632
Fundamentals Value
Market Cap 2.5 Billion
Num Shares 75.5 Million
EPS -8.82
Price-to-Earnings (P/E) Ratio -3.75
Price-to-Sales 2.45
Price-to-Book 1743.27
PEG Ratio 0.81
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 34.69
Resistance 3 (R3) 34.79 34.37 34.42
Resistance 2 (R2) 34.37 33.96 34.31 34.33
Resistance 1 (R1) 33.73 33.71 33.52 33.63 34.24
Pivot Point 33.31 33.31 33.20 33.25 33.31
Support 1 (S1) 32.67 32.90 32.46 32.57 31.95
Support 2 (S2) 32.25 32.65 32.19 31.86
Support 3 (S3) 31.61 32.25 31.77
Support 4 (S4) 31.51